Global Nuclear Receptor ROR Gamma Market Research Report 2019-2025

Description

In 2019, the market size of Nuclear Receptor ROR Gamma is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Receptor ROR Gamma.

This report studies the global market size of Nuclear Receptor ROR Gamma, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nuclear Receptor ROR Gamma sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Genfit SA
GlaxoSmithKline Plc
Aurigene Discovery Technologies Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Biogen Inc
AbbVie Inc
Advinus Therapeutics Ltd
Brickell Biotech Inc
Pfizer Inc
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd
Lead Pharma Holding BV

Market Segment by Product Type
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others

Market Segment by Application
Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Nuclear Receptor ROR Gamma status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nuclear Receptor ROR Gamma manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Nuclear Receptor ROR Gamma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type (2019-2025)
1.3.2 BBI-6000
1.3.3 GRC-39815Action
1.3.4 R&D Progress
1.3.5 GSK-2981278
1.3.6 IMU-366
1.3.7 INV-17
1.3.8 Others
1.4 Market Segment by Application
1.4.1 Global Nuclear Receptor ROR Gamma Market Share by Application (2019-2025)
1.4.2 Chronic Obstructive Pulmonary Disease
1.4.3 Asthma
1.4.4 Axial Spondyloarthritis
1.4.5 Breast Cancer
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Nuclear Receptor ROR Gamma Market Size
2.1.1 Global Nuclear Receptor ROR Gamma Revenue 2014-2025
2.1.2 Global Nuclear Receptor ROR Gamma Sales 2014-2025
2.2 Nuclear Receptor ROR Gamma Growth Rate by Regions
2.2.1 Global Nuclear Receptor ROR Gamma Sales by Regions 2014-2019
2.2.2 Global Nuclear Receptor ROR Gamma Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
3.1.1 Nuclear Receptor ROR Gamma Sales by Manufacturers 2014-2019
3.1.2 Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Nuclear Receptor ROR Gamma Revenue by Manufacturers (2014-2019)
3.2.2 Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Nuclear Receptor ROR Gamma Market Concentration Ratio (CR5 and HHI)
3.3 Nuclear Receptor ROR Gamma Price by Manufacturers
3.4 Key Manufacturers Nuclear Receptor ROR Gamma Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Nuclear Receptor ROR Gamma Market
3.6 Key Manufacturers Nuclear Receptor ROR Gamma Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 BBI-6000 Sales and Revenue (2014-2019)
4.1.2 GRC-39815Action Sales and Revenue (2014-2019)
4.1.3 R&D Progress Sales and Revenue (2014-2019)
4.1.4 GSK-2981278 Sales and Revenue (2014-2019)
4.1.5 IMU-366 Sales and Revenue (2014-2019)
4.1.6 INV-17 Sales and Revenue (2014-2019)
4.1.7 Others Sales and Revenue (2014-2019)
4.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Type
4.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type
4.4 Nuclear Receptor ROR Gamma Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Nuclear Receptor ROR Gamma Sales by Application

6 United States
6.1 United States Nuclear Receptor ROR Gamma Breakdown Data by Company
6.2 United States Nuclear Receptor ROR Gamma Breakdown Data by Type
6.3 United States Nuclear Receptor ROR Gamma Breakdown Data by Application

7 European Union
7.1 European Union Nuclear Receptor ROR Gamma Breakdown Data by Company
7.2 European Union Nuclear Receptor ROR Gamma Breakdown Data by Type
7.3 European Union Nuclear Receptor ROR Gamma Breakdown Data by Application

8 China
8.1 China Nuclear Receptor ROR Gamma Breakdown Data by Company
8.2 China Nuclear Receptor ROR Gamma Breakdown Data by Type
8.3 China Nuclear Receptor ROR Gamma Breakdown Data by Application

9 Rest of World
9.1 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Company
9.2 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Type
9.3 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Application
9.4 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Countries
9.4.1 Rest of World Nuclear Receptor ROR Gamma Sales by Countries
9.4.2 Rest of World Nuclear Receptor ROR Gamma Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Genfit SA
10.1.1 Genfit SA Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.1.4 Nuclear Receptor ROR Gamma Product Introduction
10.1.5 Genfit SA Recent Development
10.2 GlaxoSmithKline Plc
10.2.1 GlaxoSmithKline Plc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.2.4 Nuclear Receptor ROR Gamma Product Introduction
10.2.5 GlaxoSmithKline Plc Recent Development
10.3 Aurigene Discovery Technologies Ltd
10.3.1 Aurigene Discovery Technologies Ltd Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.3.4 Nuclear Receptor ROR Gamma Product Introduction
10.3.5 Aurigene Discovery Technologies Ltd Recent Development
10.4 Beijing Hanmi Pharmaceutical Co Ltd
10.4.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.4.4 Nuclear Receptor ROR Gamma Product Introduction
10.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
10.5 Biogen Inc
10.5.1 Biogen Inc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.5.4 Nuclear Receptor ROR Gamma Product Introduction
10.5.5 Biogen Inc Recent Development
10.6 AbbVie Inc
10.6.1 AbbVie Inc Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.6.4 Nuclear Receptor ROR Gamma Product Introduction
10.6.5 AbbVie Inc Recent Development
10.7 Advinus Therapeutics Ltd
10.7.1 Advinus Therapeutics Ltd Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.7.4 Nuclear Receptor ROR Gamma Product Introduction
10.7.5 Advinus Therapeutics Ltd Recent Development
10.8 Brickell Biotech Inc
10.8.1 Brickell Biotech Inc Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.8.4 Nuclear Receptor ROR Gamma Product Introduction
10.8.5 Brickell Biotech Inc Recent Development
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.9.4 Nuclear Receptor ROR Gamma Product Introduction
10.9.5 Pfizer Inc Recent Development
10.10 Phenex Pharmaceuticals AG
10.10.1 Phenex Pharmaceuticals AG Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
10.10.4 Nuclear Receptor ROR Gamma Product Introduction
10.10.5 Phenex Pharmaceuticals AG Recent Development
10.11 Reata Pharmaceuticals Inc
10.12 Bristol-Myers Squibb Company
10.13 Celgene Corp
10.14 Eli Lilly and Company
10.15 Glenmark Pharmaceuticals Ltd
10.16 Lead Pharma Holding BV

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Nuclear Receptor ROR Gamma Sales Channels
11.2.2 Nuclear Receptor ROR Gamma Distributors
11.3 Nuclear Receptor ROR Gamma Customers

12 Market Forecast
12.1 Global Nuclear Receptor ROR Gamma Sales and Revenue Forecast 2019-2025
12.2 Global Nuclear Receptor ROR Gamma Sales Forecast by Type
12.3 Global Nuclear Receptor ROR Gamma Sales Forecast by Application
12.4 Nuclear Receptor ROR Gamma Forecast by Regions
12.4.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Regions 2019-2025
12.4.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample